XBIOTECH INC. Comprehensive Income
XBIOTECH INC. (XBIT) reported Comprehensive Income of -$38.53 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-03-18
- XBIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$10.51M.
- XBIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$5.01M.
- XBIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$13.01M.
- XBIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$10.00M.
- XBIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$38.53M.
- XBIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$25.38M.
- XBIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$34.05M.
- XBIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$16.71M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$10.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$15.52M derived: sum of 2 quarters · filed 2025-03-18 | -$28.53M derived: sum of 3 quarters · filed 2025-03-18 | -$38.53M 10-K · filed 2025-03-18 |
| 2024-09-30 | -$5.01M 10-Q · filed 2024-11-13 | -$18.02M derived: sum of 2 quarters · filed 2024-11-13 | -$28.02M 10-Q · filed 2024-11-13 | -$33.10M derived: sum of 4 quarters · filed 2025-03-18 |
| 2024-06-30 | -$13.01M 10-Q · filed 2024-08-12 | -$23.01M 10-Q · filed 2024-08-12 | -$28.08M derived: sum of 3 quarters · filed 2025-03-18 | -$35.45M derived: sum of 4 quarters · filed 2025-03-18 |
| 2024-03-31 | -$10.00M 10-Q · filed 2024-05-10 | -$15.08M derived: sum of 2 quarters · filed 2025-03-18 | -$22.44M derived: sum of 3 quarters · filed 2025-03-18 | -$31.18M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-12-31 | -$5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$12.44M derived: sum of 2 quarters · filed 2025-03-18 | -$21.18M derived: sum of 3 quarters · filed 2025-03-18 | -$25.38M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$7.36M 10-Q · filed 2024-11-13 | -$16.11M derived: sum of 2 quarters · filed 2024-11-13 | -$20.31M 10-Q · filed 2024-11-13 | -$25.75M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$8.74M 10-Q · filed 2024-08-12 | -$12.94M 10-Q · filed 2024-08-12 | -$18.39M derived: sum of 3 quarters · filed 2024-08-12 | -$30.50M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$4.20M 10-Q · filed 2024-05-10 | -$9.65M derived: sum of 2 quarters · filed 2024-05-10 | -$21.76M derived: sum of 3 quarters · filed 2024-05-10 | -$32.97M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$17.56M derived: sum of 2 quarters · filed 2024-03-15 | -$28.77M derived: sum of 3 quarters · filed 2024-03-15 | -$34.05M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$12.11M 10-Q · filed 2023-11-09 | -$23.33M derived: sum of 2 quarters · filed 2023-11-09 | -$28.60M 10-Q · filed 2023-11-09 | -$34.76M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$11.21M 10-Q · filed 2023-08-11 | -$16.49M 10-Q · filed 2023-08-11 | -$22.64M derived: sum of 3 quarters · filed 2023-08-11 | -$26.15M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$5.27M 10-Q · filed 2022-05-10 | -$11.43M derived: sum of 2 quarters · filed 2023-03-15 | -$14.93M derived: sum of 3 quarters · filed 2023-03-15 | -$19.73M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-12-31 | -$6.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$9.66M derived: sum of 2 quarters · filed 2023-03-15 | -$14.46M derived: sum of 3 quarters · filed 2023-03-15 | -$16.71M 10-K · filed 2023-03-15 |
| 2021-09-30 | -$3.50M 10-Q · filed 2022-11-09 | -$8.30M derived: sum of 2 quarters · filed 2022-11-09 | -$10.55M 10-Q · filed 2022-11-09 | -$10.69M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$4.80M 10-Q · filed 2022-08-10 | -$7.05M 10-Q · filed 2022-08-10 | -$7.19M derived: sum of 3 quarters · filed 2022-08-10 | -$10.01M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$2.25M 10-Q · filed 2022-05-10 | -$2.39M derived: sum of 2 quarters · filed 2022-05-10 | -$5.21M derived: sum of 3 quarters · filed 2022-05-10 | -$12.18M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$2.96M derived: sum of 2 quarters · filed 2022-03-15 | -$9.93M derived: sum of 3 quarters · filed 2022-03-15 | -$9.85M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$2.82M 10-Q · filed 2021-11-09 | -$9.78M derived: sum of 2 quarters · filed 2021-11-09 | -$9.71M 10-Q · filed 2021-11-09 | $676.47M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$6.96M 10-Q · filed 2021-08-09 | -$6.89M 10-Q · filed 2021-08-09 | $679.29M derived: sum of 3 quarters · filed 2022-03-15 | $673.41M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$76.00K 10-Q · filed 2021-05-10 | $686.25M derived: sum of 2 quarters · filed 2022-03-15 | $680.38M derived: sum of 3 quarters · filed 2022-03-15 | $674.43M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $686.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $680.46M derived: sum of 2 quarters · filed 2022-03-15 | $674.50M derived: sum of 3 quarters · filed 2022-03-15 | $668.78M 10-K · filed 2022-03-15 |
| 2019-09-30 | -$5.88M 10-Q · filed 2020-11-09 | -$11.83M derived: sum of 2 quarters · filed 2020-11-09 | -$17.55M 10-Q · filed 2020-11-09 | -$23.57M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | -$5.95M 10-Q · filed 2020-08-10 | -$11.68M 10-Q · filed 2020-08-10 | -$17.69M derived: sum of 3 quarters · filed 2021-03-16 | -$22.71M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | -$5.73M 10-Q · filed 2020-05-11 | -$11.74M derived: sum of 2 quarters · filed 2021-03-16 | -$16.76M derived: sum of 3 quarters · filed 2021-03-16 | -$22.29M derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | -$6.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$11.04M derived: sum of 2 quarters · filed 2021-03-16 | -$16.56M derived: sum of 3 quarters · filed 2021-03-16 | -$20.63M 10-K · filed 2021-03-16 |
| 2018-09-30 | -$5.02M 10-Q · filed 2019-11-12 | -$10.55M derived: sum of 2 quarters · filed 2019-11-12 | -$14.61M 10-Q · filed 2019-11-12 | -$22.01M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | -$5.53M 10-Q · filed 2019-08-09 | -$9.59M 10-Q · filed 2019-08-09 | -$16.99M derived: sum of 3 quarters · filed 2020-03-16 | -$23.48M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | -$4.06M 10-Q · filed 2019-05-09 | -$11.46M derived: sum of 2 quarters · filed 2020-03-16 | -$17.96M derived: sum of 3 quarters · filed 2020-03-16 | -$27.58M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | -$7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$13.90M derived: sum of 2 quarters · filed 2020-03-16 | -$23.52M derived: sum of 3 quarters · filed 2020-03-16 | -$33.98M 10-K · filed 2020-03-16 |
| 2017-09-30 | -$6.50M 10-Q · filed 2018-10-31 | -$16.12M derived: sum of 2 quarters · filed 2018-10-31 | -$26.57M 10-Q · filed 2018-10-31 | -$42.75M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | -$9.63M 10-Q · filed 2018-08-09 | -$20.08M 10-Q · filed 2018-08-09 | -$36.26M derived: sum of 3 quarters · filed 2019-03-15 | -$48.72M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | -$10.45M 10-Q · filed 2018-05-08 | -$26.63M derived: sum of 2 quarters · filed 2019-03-15 | -$39.09M derived: sum of 3 quarters · filed 2019-03-15 | -$52.74M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | -$16.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | -$28.64M derived: sum of 2 quarters · filed 2019-03-15 | -$42.28M derived: sum of 3 quarters · filed 2019-03-15 | -$52.50M 10-K/A · filed 2019-03-15 |
| 2016-09-30 | -$12.46M 10-Q · filed 2017-11-09 | -$26.11M derived: sum of 2 quarters · filed 2017-11-09 | -$36.33M 10-Q · filed 2017-11-09 | -$48.41M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | -$13.65M 10-Q · filed 2017-08-08 | -$23.87M 10-Q · filed 2017-08-08 | -$35.95M derived: sum of 3 quarters · filed 2018-03-16 | -$46.76M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | -$10.22M 10-Q · filed 2017-05-10 | -$22.30M derived: sum of 2 quarters · filed 2018-03-16 | -$33.11M derived: sum of 3 quarters · filed 2018-03-16 | -$39.54M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$12.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$22.89M derived: sum of 2 quarters · filed 2018-03-16 | -$29.32M derived: sum of 3 quarters · filed 2018-03-16 | -$37.53M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$10.81M 10-Q · filed 2016-11-14 | -$17.24M derived: sum of 2 quarters · filed 2016-11-14 | -$25.45M 10-Q · filed 2016-11-14 | -$31.82M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | -$6.43M 10-Q · filed 2016-08-12 | -$14.64M 10-Q · filed 2016-08-12 | -$21.00M derived: sum of 3 quarters · filed 2017-03-16 | -$27.87M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | -$8.21M 10-Q · filed 2016-05-13 | -$14.58M derived: sum of 2 quarters · filed 2017-03-16 | -$21.44M derived: sum of 3 quarters · filed 2017-03-16 | -$25.36M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | -$6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$13.23M derived: sum of 2 quarters · filed 2017-03-16 | -$17.15M derived: sum of 3 quarters · filed 2017-03-16 | -$21.74M 10-K · filed 2017-03-16 |
| 2014-09-30 | -$6.86M 10-Q · filed 2015-11-13 | -$10.79M derived: sum of 2 quarters · filed 2015-11-13 | -$15.38M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | -$3.92M 10-Q · filed 2015-08-14 | -$8.51M 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | -$4.59M 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | -$9.93M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |